Pfizer and BioNTech to Submit Emergency Authorization for Coronavirus Vaccine Today The drug companies are seeking the first coronavirus vaccine regulatory OK in the United States from the FDA.

By Entrepreneur Staff

entrepreneur daily
Anadolu Agency | Getty Images

Pfizer and BioNTech say that their vaccine, called BNT162b2, could be available by the middle to end of December. Distribution would begin with high-risk populations in the United States.

The final analysis of Phase 3 of the clinical trial found that BNT162b2 was 95% effective in preventing infections and caused no serious safety concerns. This is based on a trial pool of 43,000 volunteers.

Related: A Year Ago, 'Patient 1' Was Infected With Covid-19

"Filing in the U.S. represents a critical milestone in our journey to deliver a Covid-19 vaccine to the world, and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential," Pfizer CEO Albert Bourla said in a statement.

As explained by CNN, an Emergency use authorization (or EUA) is not the same as full approval. It allows a product to be used in advance of all evidence being available for approval. For the FDA to grant the EUA, it will determine whether the vaccine's "known and potential benefits outweigh its known and potential risks."

Entrepreneur Staff

Entrepreneur Staff

Editor

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Related Topics

Living

The CEO of Catholic Prayer and Meditation App Hallow Says Founders Need to Be Part of Something Bigger Than Themselves

On this episode of "The CEO Series," learn about the soulful journey of Hallow's CEO and founder Alex Jones.

Business Ideas

55 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Business Solutions

Get More Done with ChatGPT for Just $20

This ChatGPT course can help you streamline your business.

Growing a Business

Lifetime Access to Business Advice with This AI-Powered Service is Just $29.99

With Consultio Pro, you'll find expertise on topics like data analysis, financial analysis, innovation management, and so much more.

Business Solutions

Stay Organized with This Task Management Tool, on Sale for $30

A Study Planr Pro subscription is just $30 for life.